Dr Balaji Ganeshan presents TexRAD at the prestigious Beijing Society of Radiology Conference.
On Saturday September 9th 2017, Dr Balaji Ganeshan, CEO of TexRAD Ltd and Director of New Business at Feedback Plc gave a keynote lecture entitled “TexRAD Texture Analysis of CT and MR images – ready for prime time?” at the prestigious Beijing Radiation Academic Annual Conference.
Dr. Ganeshan spoke on CT and MRI texture analysis in cancer imaging which is a very topical area of interest in medical imaging and TexRAD is at the forefront of this development. Evidence that currently supports the potential use of TexRAD in different clinical applications and its utility as part of the qualification process for its use in routine clinical practice was further discussed.
Pictures below show Dr Ganeshan receiving a Certificate of Appreciation from Professor H.D.Xue – Assistant Director of Radiology at Peking Union Medical College Hospital and a Committee member of the Beijing Society of Radiology.
Pictures below show Dr Ganeshan with Xiaowei Ni, CEO of Boya Digital Technology (Beijing) Co. Ltd, and members of the GE-China team including Zhuang Wei, Director of HCIT-GE-China. Dr Ganeshan is also shown with members of the GE-China team outside Beijing University Third Hospital.
Cancer Care Commission (CCC) is a UK company based in Oxford working with NHS trusts to help improve their clinical pathways for cancer care. CCC are partnering with China Resources Phoenix Health Group (CRPHG), who are a very large company owning over a hundred health facilities. CRPHG own Beijing-Yanhua-Hospital, and are partnering with Beijing 5th cancer hospital and CCC to try and create a centre of excellence for cancer care in North China. Pictures below show Dr Ganeshan presenting TexRAD with Boya CEO Xiaowei Ni, Dr Fred Sun, Sudhakar Jayaram, Dr Hongxia Yu and Dr Dadong Li, UK Trade & Investment Manager, Life Science. Dr Li’s team organised the meeting at Yanhua hospital.
